USE OF EARLY APOPTOTIC CELLS FOR TREATING COVID-19

摘要

Compositions disclosed herein, and methods of use thereof included those for treating or preventing SARS-CoV-2 virus infection in a subject in need, including methods of extending of the survival of a subject suffering from COVID-19, and reduction of organ dysfunction or failure due to COVID-19 or associated symptoms. Methods of treating or preventing COVID-19 in a subject in need includes administering compositions comprising early apoptotic cells or early apoptotic cell supernatants. Compositions and methods of use thereof may reduce the negative proinflammatory effect accompanying COVID-19 and symptoms thereof. Further, anti- inflammatory cytokine release may be increased. In certain instances, compositions may include additional agents.